A recent article in The Wall Street Journal explained the innovative idea of using the web to monitor post-trial patients. The article shared that researchers can analyze patient comments in online chats and websites to watch for drug reactions. By monitoring the web, reactions can be found much faster than the usual approach of reporting side effects. In certain cases, drugs are recalled years after they have been marketed. FiercePharma’s Tracy Staton noted in a separate commentary that the system now relies on “doctors, drug makers and patients to report any problems themselves.” (Staton) Allowing patients to post comments and news on websites could be much more efficient than the current process.

Need any assistance with post trial follow up? Contact us as contact@pearlpathways.com